Strides Pharma Science submits press release

27 Aug 2019

Strides Pharma Science has informed about submission of press release issued by the Company titled: ‘Strides acquires USFDA approved manufacturing facility in the US’.

The above information is a part of company’s filings submitted to BSE.

Related Strides Pharma Science Ltd. Links:

Strides Pharma Scien Share Price

413.15 0.15 (0.04%) Jul 03, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 476.90
Lupin 899.35
Dr. Reddys Lab 3920.95
Piramal Enterprises 1411.45
Cadila Healthcare 366.25
View more..
Sensex vs Strides Pharma Scien
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback